勝任細胞市場規模、佔有率、成長分析，按類型、按應用、按最終用戶、按地區 - 行業預測，2025-2032 年

2023年勝任細胞的全球市場規模為21.3億美元，從2024年的23億美元成長到2032年的42.9億美元，預計在預測期內（2025-2032年）複合年成長率為8.1%。為美元。

由於公共和私營部門對分子克隆研究的投資不斷增加，全球勝任細胞市場正在顯著成長。大腸桿菌具有透過氯化鈣和熱激技術整合染色體外DNA的獨特能力，這使其對研究人員具有吸引力。這些方法創建滲透性的細胞壁並促進 DNA 轉化，這對於各種應用至關重要。此外，消費者對分子克隆產品的需求不斷成長，加上醫療保健支出的增加以及對此類解決方案的認知不斷增強，進一步推動了市場擴張。政府支持研究經費和人口成長的措施也對市場動態做出了積極貢獻，為感受態細胞技術的創新和開發創造了良好的環境。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析
• 技術分析
• 監管分析
• 專利分析
• 案例研究

勝任細胞市場規模：依類型

• 市場概況
• 化學勝任細胞
• 電感受態勝任細胞

勝任細胞市場規模：依應用分類

• 市場概況
• 複製
• 亞克隆和常規克隆
• 噬菌體展示庫的構建
• 有毒/不穩定的 DNA 克隆
• 高通量克隆
• 蛋白質表現
• 其他用途
• 誘變
• 單鏈DNA 的生成
• 慢病毒載體的生產
• 大質體轉化

勝任細胞市場規模：依最終用戶分類

• 市場概況
• 製藥和生物技術公司
• 學術研究所
• 合約研究組織（CRO）

勝任細胞市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Merck KGaA（Germany）
• Promega Corporation（US）
• Thermo Fisher Scientific, Inc.（US）
• New England Biolabs（US）
• Takara Bio（Japan）
• Agilent Technologies（US）
• Lucigen（Epicenter）（Illumina）（US）
• QIAGEN NV（Germany）
• OriGene Technologies（US）
• Bioline（UK）
• Zymo Research（US）
• Beijing TransGen Biotech Co., Ltd.（China）
• Source BioScience（UK）
• IBA GmbH（Germany）
• Genewiz（US）
• BioDynamics Laboratory, Inc.（Japan）
• GCC Biotech（India）
• SMOBIO Technology（Taiwan）
• GeneScript Corporation（US）
• Bio-Rad Laboratories（US）

結論和建議

Global Competent Cells Market size was valued at USD 2.13 billion in 2023 and is poised to grow from USD 2.3 billion in 2024 to USD 4.29 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global competent cells market is experiencing significant growth, driven by increased investments from both public and private sectors in molecular cloning research. E. coli's unique ability to integrate extrachromosomal DNA through techniques involving calcium chloride and heat shock is compelling for researchers. These methods create permeable cell walls, facilitating DNA transformation essential for various applications. Additionally, rising consumer demand for molecularly cloned products, coupled with growing healthcare expenditures and heightened awareness of these solutions, further bolsters market expansion. Government initiatives supporting research funding and population growth also contribute positively to the market's dynamics, underscoring a robust environment for innovation and development in competent cell technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Competent Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Competent Cells Market Segmental Analysis

Global Competent Cells Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Chemically Competent Cells and Electrocompetent Cells. Based on Application, the market is segmented into Cloning, Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-throughput Cloning, Protein Expression, Other Applications, Mutagenesis, Single-stranded DNA Production, Lentiviral Vector Production and Large Plasmid Transformation. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Competent Cells Market

The global competent cells market is poised for growth, largely propelled by favorable government initiatives and the surging demand for products developed through recombinant DNA technology, alongside advancements in molecular engineering. Over the coming years, this market is expected to thrive due to heightened research and development efforts aimed at creating therapeutic items addressing various health conditions, coupled with beneficial reimbursement and regulatory frameworks. Furthermore, a growing commercial interest in molecularly cloned products and recombinant proteins, alongside increased government investment in research activities, is anticipated to significantly enhance market potential throughout the next decade.

Restraints in the Global Competent Cells Market

The Global Competent Cells market is likely to face several constraints hindering its growth. One significant factor is the high cost associated with competent cell kits, which can deter potential market entrants and limit accessibility for smaller research facilities. Furthermore, the increasing market consolidation is raising entry barriers, making it challenging for new players to compete. Compounding these issues, a shortage of skilled professionals with expertise in this field is expected to pose an additional challenge during the forecast period, ultimately impeding the overall expansion of the competent cells market.

Market Trends of the Global Competent Cells Market

The Global Competent Cells market is poised for significant growth, driven by the rising demand for molecular cloning applications across various sectors. Increasing investments in cloning research, coupled with financial support from governmental and private organizations, are propelling advancements in cell engineering techniques like somatic cell nuclear transfer (SCNT). These technologies are pivotal in producing transgenic animals, preserving endangered species, and advancing therapeutic cloning. As competent cells play a crucial role in these innovative research areas, the market is expected to attract renewed interest and investment, resulting in a robust upward trend in demand for competent cells worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Competent Cells Market Size by Type & CAGR (2025-2032)

• Market Overview
• Chemically Competent Cells
• Electrocompetent Cells

Global Competent Cells Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cloning
• Subcloning & Routine Cloning
• Phage Display Library Construction
• Toxic/Unstable DNA Cloning
• High-throughput Cloning
• Protein Expression
• Other Applications
• Mutagenesis
• Single-stranded DNA Production
• Lentiviral Vector Production
• Large Plasmid Transformation

Global Competent Cells Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations (CROs)

Global Competent Cells Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucigen (Epicenter) (Illumina) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Source BioScience (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioDynamics Laboratory, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GCC Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMOBIO Technology (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneScript Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations